SCHEMBL2069232

SCHEMBL2069232

COC(=O)c1ccccc1N1CCCC(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.52
PIM3 Q86V86 1/20 0.52
PIM2 Q9P1W9 1/20 0.52
BTK Q06187 3/20 0.50
MAP4K4 O95819 2/20 0.49
PDE10A Q9Y233 1/20 0.49
JAK3 P52333 1/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
DRD2 P14416 3/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DPP4 P27487 1/20 0.43
AURKA O14965 3/20 0.43
PDPK1 O15530 3/20 0.43
AURKB Q96GD4 3/20 0.43
CTSK P43235 2/20 0.43
DRD3 P35462 1/20 0.43
CKS1B P61024 1/20 0.42
SKP1 P63208 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15608911 1.00 PIM1 (0.52) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL13156648 0.87 MAP4K4 (0.56) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL13156657 0.87 MAP4K4 (0.56) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL4553425 0.87 MAP4K4 (0.56) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL23497661 0.85 BTK (0.49) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL12283923 0.83 PIM1 (0.60) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL12074150 0.82 CNR1 (0.55) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL19657343 0.82 CNR1 (0.55) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL13156658 0.81 ALDH1A1 (0.53) PIM1PIM3PIM2BTKMAP4K4
SCHEMBL11908583 0.81 ALDH1A1 (0.53) PIM1PIM3PIM2BTKMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
CN-101014595-A Novel cyclic aminobenzoic acid derivative KYORIN SEIYAKU KK (JP) 2007-08-08 CN disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative PPARA, PPARG, PPARD PIM1 3266/4885PIM3 4076/4885PIM2 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.